Summary of Warrants Outstanding (Details) - Warrant [Member] |
9 Months Ended |
|---|---|
|
Sep. 30, 2022
$ / shares
shares
| |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Number of Warrants, Beginning Balance | 40,000 |
| Weighted Average Exercise Price, Beginning Balance | $ / shares | $ 1.00 |
| Number of Warrants, Granted | |
| Weighted Average Exercise Price, Granted | |
| Number of Warrants, Exercised | |
| Weighted Average Exercise Price, Exercised | |
| Number of Warrants, Expired | |
| Weighted Average Exercise Price, Expired | $ / shares | |
| Number of Warrants, Ending Balance | 40,000 |
| Weighted Average Exercise Price, Ending Balance | $ / shares | $ 1.00 |
| X | ||||||||||
- Definition Share based Compensation Arrangement by Share Based Payment Award Non Option Equity Instruments Exercises in Period Weighted Average Exercise Price. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, expired No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, beginning balance No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|